Article Text

Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features
  1. N G LAING
  1. Australian Neuromuscular Research Institute, 4th Floor, A Block, Queen Elizabeth II, Medical Centre, Nedlands, Western Australia 6009, Australia
  2. Department of Neurology and Cell and Molecular Biology, Tarry Building 13-715, Northwestern University Medical School, 303 E. Chicago Avenue, Chicago, IL 60611, USA
  1. Dr N G Laing, Australian Neuromuscular Research Institute, 4th Floor, A Block, Queen Elizabeth II, Medical Centre, Nedlands, Western Australia 6009, Australia.
  1. T SIDDIQUE
  1. Australian Neuromuscular Research Institute, 4th Floor, A Block, Queen Elizabeth II, Medical Centre, Nedlands, Western Australia 6009, Australia
  2. Department of Neurology and Cell and Molecular Biology, Tarry Building 13-715, Northwestern University Medical School, 303 E. Chicago Avenue, Chicago, IL 60611, USA
  1. Dr N G Laing, Australian Neuromuscular Research Institute, 4th Floor, A Block, Queen Elizabeth II, Medical Centre, Nedlands, Western Australia 6009, Australia.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We refer to the article by Radunović et al 1 and the kindred referred to in this article and in the article by Cleveland et al 2 as the Australian superoxide dismutase (SOD1) Gly37Arg familial amyotrophic lateral sclerosis (FALS) kindred. It did seem extraordinary that the same mutation should produce such different disease phenotypes in two separate continents. Investigations in Australia, subsequent to the publication of the paper by Cleveland et al,2identified the mutation in this family as His43Arg, not Gly37Arg. The mutation was identified as H43R by …

View Full Text